Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease

Ophthalmology. 2007 Jan;114(1):99-103. doi: 10.1016/j.ophtha.2006.07.043.

Abstract

Objective: Recently, a strong association has been observed for the complement factor H (CFH) Tyr402His polymorphism with early and advanced age-related macular degeneration (AMD) in independent non-Hispanic White, clinic-based, case-control studies. These studies suggest the CFH His402 allele is a major risk allele in early and advanced AMD, explaining 43% to 70% of all AMD in older adults. We utilized a population-based case-control study design of early AMD among Latinos/Hispanics to evaluate the CFH Tyr402His polymorphism for an association with early AMD phenotypes.

Design: Retrospective population-based case-control study.

Participants: This study cohort consists of 285 early AMD cases and 570 controls matched on age, birthplace, and smoking status.

Methods: Genotype determination was performed by allele-specific digestion of polymerase chain reaction products.

Main outcome measures: Complement factor H Tyr402His polymorphism.

Results: We observed no overall statistically significant association with early AMD among Latinos. However, a subset of early AMD cases that have bilateral, not unilateral, intermediate-to-large soft macular drusen were 1.7 times more likely to carry either the homozygous or heterozygous His402 genotype.

Conclusions: Our data suggest that the CFH Tyr402His is not a major risk factor for overall early AMD in this Latino population, but may play a role in susceptibility to phenotypes of early AMD likely to progress to late AMD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Case-Control Studies
  • Complement Factor H / genetics
  • Female
  • Functional Laterality / genetics*
  • Genotype
  • Hispanic or Latino / ethnology
  • Humans
  • Macular Degeneration / ethnology
  • Macular Degeneration / genetics*
  • Male
  • Middle Aged
  • Phenotype
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide*
  • Retrospective Studies
  • Risk Factors

Substances

  • CFH protein, human
  • Complement Factor H